A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

NCT07096791 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Postpartum Depressive Disorder

Interventions

DRUG: KH607 tablet
DRUG: placebo

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.